Retatrutide (20 mg Vial)
Working reference for Retatrutide (20 mg Vial). Reconstitution volume and resulting concentration, dose-to-syringe-unit conversion on a U-100 insulin syringe, consumables per protocol length, and storage requirements.
CAT No:
CAS No:
Synonyms/Alias:Retatrutide
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
Working reference for Retatrutide (20 mg Vial). Reconstitution volume and resulting concentration, dose-to-syringe-unit conversion on a U-100 insulin syringe, consumables per protocol length, and storage requirements.
Quickstart
Reconstitute: Add 2.0 mL bacteriostatic water → ~ 10.0 mg/mL concentration.
Typical weekly range: 2–8 mg once weekly (gradual escalation over 8–12 weeks).
Easy measuring: At 10.0 mg/mL, 1 unit = 0.01 mL ≈ 100 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks.
Notes
Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a sharps container [14]. Rotate injection sites (abdomen, thighs, upper arms) systematically to reduce local irritation and lipohypertrophy [13]. For volumes >1.0 mL, split into 2 separate injections at different sites for better absorption [5]. Inject slowly; wait a few seconds before withdrawing the needle to ensure full dose delivery. Document weekly dose, date, and injection sites to maintain consistency. Gradual titration is essential to minimize gastrointestinal side ef
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Retatrutide, 20 mg each): 12 weeks (Standard to 6 mg): 3 vials
24 weeks (Standard to 8 mg): 8 vials
12 weeks (Aggressive to 8 mg): 3 vials
Insulin Syringes (U-100, 1 mL capacity): Per week: 1–2 syringes (depending on dose; higher doses require split injections)
12 weeks: 12–24 syringes
24 weeks: 24–48 syringes
Bacteriostatic Water (10 mL bottles): Use ~2.0 mL per vial for reconstitution. 12 weeks (3 vials): 6 mL → 1 × 10 mL bottle
24 weeks (8 vials): 16 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for each injection site. Per week: 2–4 swabs (1 per vial + 1–2 per injection site)
12 weeks: ~50 swabs → recommend 1 × 100-count box
24 weeks: ~100 swabs → recommend 1 × 100-count box
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China